Pharma-Bio Serv, Inc.
corporate_fare Company Profile
Pharma-Bio Serv, Inc. (OTC:PBSV) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 7 items for PBSV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-15, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for PBSV spans 10-Q, DEF 14A, 10-K/A, 8-K.
Recent high-impact activity:
- Pharma-Bio Serv Q2 Revenue Jumps 11.8% to $2.7M, EPS Up 150%
- Pharma-Bio Serv Reports Strong Net Income Growth and Revenue Rebound in Q2
- Pharma-Bio Serv Discloses Material Related-Party AI Investment and Sets Annual Meeting Agenda
- Pharma-Bio Serv Declares Substantial Cash Dividend, Boosts Liquidity Despite Revenue Dip
- Pharma-Bio Serv Amends 10-K to Disclose Significant Related-Party AI Investment and Executive Compensation
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,008 shares in PBSV as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 100.0% of PBSV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.